Company / R&D Expense
Stereotaxis, Inc. R&D Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$9.8M
FY2025
5-year range
$8.1M / $10.6M
FY2021-FY2025
Trend
-5.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D Expense has fluctuated over the past 10 years, ranging from $5M in FY2017 to $11M in FY2023.
Based on SEC 10-K filings.
$10M in FY2025 with a 5-year CAGR of +1.6%.
Declined from $11M to $10M over the past 2 years.
R&D Expense over time
Growth rates
- 3-Year CAGR
- -1.5%
- 5-Year CAGR
- +1.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +1.6%, indicating consistent growth.
- In FY2025, r&d expense decreased 5.0% year-over-year.
- Peak r&d expense was recorded in FY2023.
- Lowest r&d expense in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.74 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $9.8M | -5.0% |
| FY2024 | $10.3M | -2.7% |
| FY2023 | $10.6M | +3.5% |
| FY2022 | $10.2M | +25.3% |
| FY2021 | $8.1M | -9.8% |
| FY2020 | $9.0M | +9.8% |
| FY2019 | $8.2M | +22.6% |
| FY2018 | $6.7M | +22.2% |
| FY2017 | $5.5M | -12.2% |
| FY2016 | $6.3M | +21.2% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026